How does ALK rearrangement affect Colorectal Cancer treatment

Colorectal CancerMay 17, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case. No signup, answered right here.

or Upload your records for answers about your actual case

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Sources & medical oversight

Grounded in NCCN Guidelines for Patients: Colon Cancer — the same guidelines oncologists use.
Built by OpenCancer’s team of physician-scientists and cancer survivors.
Last updated May 17, 2026. Informational only — not a substitute for your oncology team.

ALK Rearrangement and Colorectal Cancer: An Important Clarification

I appreciate this question because it highlights an important distinction in cancer care. Let me explain what the evidence shows:

The Key Finding: ALK Rearrangements Are NOT Typically Found in Colorectal Cancer

ALK gene rearrangements are extremely rare in colorectal cancer. According to the NCCN Guidelines for Colon Cancer (Version 5.2025), ALK testing is not part of the standard biomarker panel for colorectal cancer patients.

ALK rearrangements are primarily associated with non-small cell lung cancer (NSCLC), where they occur in approximately 5% of patients. The NCCN Guidelines for NSCLC extensively detail ALK-targeted therapies like alectinib, brigatinib, ceritinib, crizotinib, and lorlatinib—but these recommendations apply to lung cancer, not colorectal cancer.

What Biomarkers DO Matter for Colorectal Cancer?

Instead, the NCCN Colon Cancer Guidelines recommend testing for these biomarkers:

KRAS/NRAS/BRAF mutations – Guide decisions about targeted therapies like cetuximab or panitumumab
HER2 amplification – Identifies patients who may benefit from HER2-targeted therapies
dMMR/MSI-H status – Determines eligibility for immunotherapy
POLE/POLD1 mutations – Associated with ultra-hypermutated tumors

Questions to Ask Your Oncologist

If you have colorectal cancer and ALK testing was mentioned:

Why was ALK testing ordered for my colorectal cancer? (It's unusual and may indicate a specific clinical reason)
What biomarkers are most relevant to my specific tumor type and stage?
Which of these results will guide my treatment decisions?
Are there any clinical trials available based on my biomarker profile?

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation. No signup, answered right here.

or Upload your records for answers about your actual case

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →